John Richards
Voorzitter bij AKTIENBRAUEREI KAUFBEUREN AG
Vermogen: - $ op 31-05-2024
Oorsprong van het eerstegraads netwerk van John Richards
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 14 | |
ImmuLogic Pharmaceutical Corp.
 ImmuLogic Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology ImmuLogic Pharmaceutical Corporation is a biopharmaceutical company. The company focuses on the research and clinical development of products to treat allergies, autoimmune diseases, and vaccines for the management of drugs of abuse. It was founded on March 26, 1987 and is headquartered in Woburn, MN.
10
| Private Company | Pharmaceuticals: Major | 10 |
Comanche Biopharma Corp.
 Comanche Biopharma Corp. Miscellaneous Commercial ServicesCommercial Services Comanche Biopharma Corp. is a maternal and fetal medicine biopharmaceutical company based in Concord, MA. The company is working to lower the risks of pregnancy and premature births worldwide by developing the world's first treatment for preeclampsia, which affects more than 10 million women every year. Comanche Biopharma's founders have had successful careers discovering new medicines, building and selling companies, and taking on some of the hardest challenges in medicine. Comanche Biopharma is committed to the ethical representation of people of all colors and economic status in their clinical development programs and prioritizes ensuring access to their solutions by those who need them most. The company was founded by Michael Young, and the CEO is T. Scott Johnson.
10
| Holding Company | Miscellaneous Commercial Services | 10 |
| Public Company | Real Estate Development | 6 | |
Zeneca Group Plc
 Zeneca Group Plc Pharmaceuticals: MajorHealth Technology Zeneca Group Plc used to develop & manufacture pharmaceutical products, agrochemicals and specialties chemicals. Its agrochemicals products include herbicides, insecticides and fungicides. The firm products were used by health care, agrochemical, paint, leather and imaging applications industries. The company was headquartered in London, UK.
2
| Extinct | Pharmaceuticals: Major | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met John Richards via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| THE MEDICINES COMPANY | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director of Finance/CFO Director of Finance/CFO General Counsel | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Sales & Marketing Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Ampersand Management LLC
 Ampersand Management LLC Investment ManagersFinance Ampersand Management LLC (Ampersand Management) is a private equity firm founded in 1988 by Richard A. Charpie. The firm is headquartered in Wellesley, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
| INVIVYD, INC. | Biotechnology | Director/Board Member Director of Finance/CFO | |
| Rokit Group of Cos. | Founder Corporate Officer/Principal | ||
| Massachusetts Institute of Technology | College/University | Doctorate Degree Doctorate Degree | |
Cequent Pharmaceuticals, Inc.
 Cequent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cequent Pharmaceuticals, Inc. developed therapeutics and pharmaceuticals. The company was founded in 2006 and was headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Bentley University | College/University | Masters Business Admin | |
American Association of Pharmaceutical Scientists
 American Association of Pharmaceutical Scientists BiotechnologyHealth Technology The American Association of Pharmaceutical Scientists engages in research and development of pharmaceutical products. The private company is based in Arlington, VA. The company was founded by Leslie Z. Benet. | Biotechnology | Corporate Officer/Principal | |
| Brown University | College/University | Graduate Degree | |
AverStar, Inc.
 AverStar, Inc. Packaged SoftwareTechnology Services AverStar, Inc. is a company based in Burlington, MA that specializes in [description not provided]. AverStar, Inc. has subsidiaries in the United States. AverStar was acquired by The Titan Corp. on June 27, 2000 for $140 million. | Packaged Software | Director of Finance/CFO | |
| University of Rhode Island | College/University | Undergraduate Degree | |
| ATAI LIFE SCIENCES N.V. | Pharmaceuticals: Major | Director/Board Member | |
Aprecia Pharmaceuticals Co.
 Aprecia Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Aprecia Pharmaceuticals Co. manufactures and develops drugs. It offers ZipDose and three dimension printing technology platforms. The firm utilizes the 3DP technology platform to develop and manufacture pharmaceutical products on a commercial scale. The company was founded in 2003 and is headquartered in Langhorne, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
FORM Life Ventures
 FORM Life Ventures Investment ManagersFinance FORM Life (FORM Life ventures) is venture capital firm founded in 2022 by Markus Okumus. FORM Life Ventures is headquartered in Luxembourg. | Investment Managers | Consultant / Advisor | |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Investment Managers | Consultant / Advisor | |
Renetx Bio, Inc.
 Renetx Bio, Inc. BiotechnologyHealth Technology Renetx Bio, Inc. operates as a biotechnology company that develops disease modifying therapeutics. It offers Nogo Receptor and Cellular Prion Protein technology. The company was founded by Sylvia McBrinn and Stephen Strittmatter in 2009 and is headquartered in New Haven, CT. | Biotechnology | Director of Finance/CFO | |
Lycia Therapeutics, Inc.
 Lycia Therapeutics, Inc. BiotechnologyHealth Technology Lycia Therapeutics, Inc. is a biotechnology company, which engages in the developing technology that utilizes lysosome-targeting chimeras. It uses LYTACs platform to discover and provide therapeutics that degrade extracellular and membrane-bound proteins that drive a range of difficult-to treat diseases, including cancers and autoimmune conditions. The company was founded by Carolyn R. Bertozzi in 2019 and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member | |
| ADVERUM BIOTECHNOLOGIES, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
dpa Deutsche Presse-Agentur GmbH
 dpa Deutsche Presse-Agentur GmbH Internet Software/ServicesTechnology Services dpa Deutsche Presse-Agentur GmbH publishes on-line news. It develops and produces multimedia news products for the Web, mobile portal, and print applications, as well as engages in managing mobile services for media companies, providing cross media services for newspapers, international still graphics, and offers picture agency services. The company was founded in 1949 and is headquartered in Hamburg, Germany. | Internet Software/Services | Director/Board Member | |
Tiziana Life Sciences Ltd. (United Kingdom)
 Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Biotechnology | Corporate Officer/Principal | |
| ACTAVIA LIFE SCIENCES, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Howard Brown Health Center
 Howard Brown Health Center Medical/Nursing ServicesHealth Services Howard Brown Health Center is a non-profit organization that provides healthcare services. It offers primary medical care, behavioral health, research, HIV/STI prevention, youth services, elder services, and community initiatives. The company was founded in 1974 and is headquartered in Chicago, IL. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer | |
| St. George's University | College/University | Doctorate Degree | |
| University of California, Los Angeles | College/University | Undergraduate Degree | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree | |
HSBC Securities (USA), Inc.
 HSBC Securities (USA), Inc. Regional BanksFinance Founded in 1969, HSBC Securities (U.S.A.) Inc. is an SEC-registered brokerage firm and registered futures commission merchant located in New York City. The firm is a wholly-owned subsidiary of HSBC North America Holdings, Inc. and their ultimate parent is HSBC Holdings Plc. (NYSE: HBC). HSBC Securities (U.S.A.) is a member of FINRA, the NYSE and the SIPC. Their securities and annuity products are provided by registered representatives and insurance agents of HSBC Securities (U.S.A.). In California, HSBC Securities (U.S.A.) conducts insurance business as HSBC Securities Insurance Services. Insurance products are offered through insurance agents of HSBC Insurance Agency (U.S.A.) Inc., a wholly-owned subsidiary of HSBC Bank U.S.A. NA and an indirectly wholly-owned subsidiary of HSBC Holdings plc. The company also engages in investment banking underwriting, dealing and brokering of debt and equity securities and futures contracts and is a primary dealer in U.S. Government and federal agency securities. | Regional Banks | Corporate Officer/Principal | |
| University of Glasgow | College/University | Doctorate Degree | |
Imperial Chemical Industries Ltd.
 Imperial Chemical Industries Ltd. Chemicals: Major DiversifiedProcess Industries Imperial Chemical Industries Ltd. manufactures chemicals and paint products. Its products include coatings, adhesives, starch, and synthetic polymer. The company was founded on December 7, 1926 and is headquartered in Slough, the United Kingdom. | Chemicals: Major Diversified | Director/Board Member | |
Oxagen Ltd.
 Oxagen Ltd. Pharmaceuticals: MajorHealth Technology Oxagen Ltd. develops novel molecule drugs to treat inflammatory and respiratory diseases. It offers OC000459, an oral CRTH2 antagonist for the treatment of eosinophilic asthma and allergic rhino conjunctivitis. The company was founded by Nick Cross, John Irving Bellin, Mark Edwards, Trevor J. Nicholls and Ian Michael Laing on September 05 1996 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| SYNGENTA | Chemicals: Agricultural | Corporate Officer/Principal | |
| University of Strathclyde | College/University | Undergraduate Degree | |
| REVO BIOLOGICS INC | Biotechnology | Director/Board Member | |
| ALLERGAN PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| MIRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
FlowCardia, Inc.
 FlowCardia, Inc. Medical SpecialtiesHealth Technology FlowCardia, Inc. designs, develops and manufactures endovascular devices. It offers flowmate Injector to optimize the performance of crosser cto recanalization and crosser catheter, a minimally-invasive endovascular device. The firm also provides portfolio of catheter-based technologies to facilitate guidewire crossing of totally occluded coronary and peripheral arteries. The company was founded by Henry Nita and Erik T. Engelson in 2001 and is headquartered in Sunnyvale, CA. | Medical Specialties | Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 36 |
| Verenigd Koninkrijk | 8 |
| Duitsland | 3 |
| Nederland | 2 |
| Luxemburg | 2 |
Sectoraal
| Health Technology | 29 |
| Consumer Services | 9 |
| Finance | 8 |
| Technology Services | 3 |
| Process Industries | 3 |
Operationeel
| Director/Board Member | 147 |
| Corporate Officer/Principal | 63 |
| Director of Finance/CFO | 44 |
| Independent Dir/Board Member | 35 |
| President | 33 |
Sterkste connecties
| Insiders | |
|---|---|
| Alan Dunton | 34 |
| Carl Goldfischer | 31 |
| Herb H. Hooper | 27 |
| Jane Henderson | 25 |
| Laurent Fischer | 23 |
| Eric Linsley | 21 |
| Clive Meanwell | 21 |
| Robert G. Savage | 19 |
| Thomas A. Shea | 15 |
| Keith Marshall | 13 |
| Jonathan Rothbard | 10 |
| Jonathan Kendrick | 9 |
| Barbara Fox | 9 |
| Michael R. Slater | 9 |
| Richard Bagley | 9 |
- Beurs
- Insiders
- John Richards
- Bedrijfsconnecties
